Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2).
The Journal Of Biological Chemistry
Stechschulte, Lance A LA; Ge, Chunxi C; Hinds, Terry D TD; Sanchez, Edwin R ER; Franceschi, Renny T RT; Lecka-Czernik, Beata B